Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of 359.92 billion. The enterprise value is 357.42 billion.
| Market Cap | 359.92B |
| Enterprise Value | 357.42B |
Important Dates
The next estimated earnings date is Wednesday, February 5, 2025.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Aug 15, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.86% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.18B |
Valuation Ratios
The trailing PE ratio is 25.41.
| PE Ratio | 25.41 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 36.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.06, with an EV/FCF ratio of 30.74.
| EV / Earnings | 25.23 |
| EV / Sales | 9.47 |
| EV / EBITDA | 19.06 |
| EV / EBIT | 20.40 |
| EV / FCF | 30.74 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.47.
| Current Ratio | 0.94 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 0.42 |
| Debt / FCF | 0.73 |
| Interest Coverage | 825.54 |
Financial Efficiency
Return on equity (ROE) is 88.73% and return on invested capital (ROIC) is 52.81%.
| Return on Equity (ROE) | 88.73% |
| Return on Assets (ROA) | 22.49% |
| Return on Capital (ROIC) | 52.81% |
| Revenue Per Employee | 563,010 |
| Profits Per Employee | 197,089 |
| Employee Count | 64,319 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 1.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.33% in the last 52 weeks. The beta is 0.17, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -23.33% |
| 50-Day Moving Average | 97.92 |
| 200-Day Moving Average | 121.81 |
| Relative Strength Index (RSI) | 38.77 |
| Average Volume (20 Days) | 41,596 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of 40.47 billion and earned 14.17 billion in profits. Earnings per share was 3.17.
| Revenue | 40.47B |
| Gross Profit | 34.26B |
| Operating Income | 18.77B |
| Pretax Income | 17.84B |
| Net Income | 14.17B |
| EBITDA | 19.91B |
| EBIT | 18.77B |
| Earnings Per Share (EPS) | 3.17 |
Balance Sheet
The company has 11.20 billion in cash and 8.52 billion in debt, giving a net cash position of 2.68 billion.
| Cash & Cash Equivalents | 11.20B |
| Total Debt | 8.52B |
| Net Cash | 2.68B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.03B |
| Book Value Per Share | 4.05 |
| Working Capital | -1.97B |
Cash Flow
In the last 12 months, operating cash flow was 17.68 billion and capital expenditures -6.05 billion, giving a free cash flow of 11.63 billion.
| Operating Cash Flow | 17.68B |
| Capital Expenditures | -6.05B |
| Free Cash Flow | 11.63B |
| FCF Per Share | n/a |
Margins
Gross margin is 84.66%, with operating and profit margins of 46.37% and 35.01%.
| Gross Margin | 84.66% |
| Operating Margin | 46.37% |
| Pretax Margin | 44.07% |
| Profit Margin | 35.01% |
| EBITDA Margin | 49.19% |
| EBIT Margin | 46.37% |
| FCF Margin | 28.73% |
Dividends & Yields
This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 0.66%.
| Dividend Per Share | 0.52 |
| Dividend Yield | 0.66% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 46.60% |
| Buyback Yield | 0.86% |
| Shareholder Yield | 1.52% |
| Earnings Yield | 3.94% |
| FCF Yield | 3.23% |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 10.12.
| Altman Z-Score | 10.12 |
| Piotroski F-Score | n/a |